
---
nice.evidencecategory: 
---

### Evidence Statement CG66HES3
In the 2001 cost-effectiveness analysis, intensive treatment with metformin cost on average
258 less than conventional treatment, and resulted in a longer life expectancy of 0.4 years.34

